Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
First Claim
Patent Images
1. A pneumostomy procedure used to create a pneumostoma through a chest wall, parietal membrane and visceral membrane into a lung of a patient, wherein the pneumostomy procedure comprises:
- (a) creating an opening through the chest wall and parietal membrane;
(b) engaging the visceral membrane of the lung;
(c) securing the visceral membrane to the parietal membrane adjacent the opening;
(d) making another opening through the visceral membrane;
(e) inserting a distal end of a pneumostomy catheter through the another opening into parenchymal tissue of the lung;
(f) expanding an expandable device at the distal end of the pneumostomy catheter to displace parenchymal tissue of the lung and secure the distal end of the pneumostomy catheter within the lung;
(g) securing the pneumostomy catheter to the chest wall of the patient;
(h) leaving the distal end of the pneumostomy catheter embedded in the parenchymal tissue to create the pneumostoma;
(i) collapsing the expandable device at the distal end of the pneumostomy catheter;
(j) removing the pneumostomy catheter from the patient after formation of the pneumostoma, wherein the pneumostoma includes an artificial channel connecting a cavity in the parenchymal tissue created by the pneumostomy catheter to the air external to the patient'"'"'s body;
(k) inserting a pneumostoma management device into the pneumostoma to protect the pneumostoma and maintain patency of the pneumostoma, wherein the pneumostoma management device has a different structure than the pneumostomy catheter; and
(l) wherein an airtight pleurodesis seal between the visceral and parietal membranes is not formed prior to performing (a), (b), (c), (d), (e), (f), and (g), thereby allowing the lung to deflate during the procedure resulting in a temporary pneumothorax.
1 Assignment
0 Petitions
Accused Products
Abstract
A single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. In a single-phase technique the pleurodesis is formed at the same time as the pneumostoma and does not require a separate step. The thoracic cavity is accessed to visualize the lung, the pneumostomy catheter is inserted into the lung and then the lung is secured to the channel through the chest wall creating a sealed anastomosis which matures into a pleurodesis after the procedure.
-
Citations
20 Claims
-
1. A pneumostomy procedure used to create a pneumostoma through a chest wall, parietal membrane and visceral membrane into a lung of a patient, wherein the pneumostomy procedure comprises:
-
(a) creating an opening through the chest wall and parietal membrane; (b) engaging the visceral membrane of the lung; (c) securing the visceral membrane to the parietal membrane adjacent the opening; (d) making another opening through the visceral membrane; (e) inserting a distal end of a pneumostomy catheter through the another opening into parenchymal tissue of the lung; (f) expanding an expandable device at the distal end of the pneumostomy catheter to displace parenchymal tissue of the lung and secure the distal end of the pneumostomy catheter within the lung; (g) securing the pneumostomy catheter to the chest wall of the patient; (h) leaving the distal end of the pneumostomy catheter embedded in the parenchymal tissue to create the pneumostoma; (i) collapsing the expandable device at the distal end of the pneumostomy catheter; (j) removing the pneumostomy catheter from the patient after formation of the pneumostoma, wherein the pneumostoma includes an artificial channel connecting a cavity in the parenchymal tissue created by the pneumostomy catheter to the air external to the patient'"'"'s body; (k) inserting a pneumostoma management device into the pneumostoma to protect the pneumostoma and maintain patency of the pneumostoma, wherein the pneumostoma management device has a different structure than the pneumostomy catheter; and (l) wherein an airtight pleurodesis seal between the visceral and parietal membranes is not formed prior to performing (a), (b), (c), (d), (e), (f), and (g), thereby allowing the lung to deflate during the procedure resulting in a temporary pneumothorax. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A surgical technique used to create a pneumostoma through a chest wall, parietal membrane and visceral membrane into a lung of a patient, wherein the following steps are performed in a single surgical procedure:
-
(a) accessing a pleural cavity through an opening in the chest wall; (b) engaging the visceral membrane of the lung; (c) inserting a distal end of a pneumostomy catheter into the lung through the visceral membrane; (d) expanding an expandable device at the distal end of the pneumostomy catheter to displace parenchymal tissue of the lung and secure the pneumostomy catheter within the lung; (e) securing the visceral membrane to the parietal membrane adjacent the opening in the chest wall; (f) securing a proximal end of the pneumostomy catheter to the chest wall of the patient; (g) leaving the distal end of the pneumostomy catheter embedded in the parenchymal tissue to create the pneumostoma; (h) collapsing the expandable device at the distal end of the pneumostomy catheter; (i) removing the pneumostomy catheter from the patient after formation of the pneumostoma, wherein the pneumostoma includes an artificial channel connecting a cavity in the parenchymal tissue created by the pneumostomy catheter to the air external to the patient'"'"'s body; (j) inserting a pneumostoma management device into the pneumostoma to protect the pneumostoma and maintain patency of the pneumostoma, wherein the pneumostoma management device has a different structure than the pneumostomy catheter; and (k) wherein an airtight pleurodesis seal between the visceral and parietal membranes is not formed prior to performance (a), (b), (c), (d), (e), and (f), thereby allowing the lung to deflate during the procedure resulting in a temporary pneumothorax. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. A surgical technique used to create a pneumostoma through a chest wall, parietal membrane and visceral membrane into a lung of a patient comprising the steps of:
-
(a) accessing a pleural cavity through an opening in the chest wall; (b) engaging the visceral membrane of the lung; (c) inserting a distal end of a pneumostomy catheter into the lung through the visceral membrane such that the distal end is positioned within and in contact with parenchymal tissue of the lung; (d) expanding an expandable device at the distal end of the pneumostomy catheter within the parenchymal tissue of the lung to displace parenchymal tissue of the lung and create a cavity within the parenchymal tissue of the lung and secure the pneumostomy catheter within the lung; (e) securing the visceral membrane to the parietal membrane adjacent the opening in the chest wall; (f) securing a proximal end of the pneumostomy catheter to the chest wall of the patient; (g) leaving the distal end of the pneumostomy catheter embedded in the parenchymal tissue to create the pneumostoma; (h) collapsing the expandable device at the distal end of the pneumostomy catheter; (i) removing the pneumostomy catheter from the patient after formation of the pneumostoma, wherein the pneumostoma includes an artificial channel connecting the cavity in the parenchymal tissue created by the pneumostomy catheter to the air external to the patient'"'"'s body; (j) inserting a pneumostoma management device into the pneumostoma to protect the pneumostoma and maintain patency of the pneumostoma, wherein the pneumostoma management device has a different structure than the pneumostomy catheter; and (k) wherein an airtight pleurodesis seal between the visceral and parietal membranes is not formed prior to performing (a), (b), (c), (d), (e), and (f), thereby allowing the lung to deflate during the procedure resulting in a temporary pneumothorax. - View Dependent Claims (16, 17, 18, 19, 20)
-
Specification